NetScientific's mission is to build a transatlantic biomedical and healthcare group funding and developing technologies that offer transformative benefits to people's lives and society. NetScientific funds, develops and manages early/mid-stage healthcare technology companies sourced from strategic partnerships and relationships in USA and Europe with a primary focus on Digital health, Diagnostics and Therapeutics. These represent highly attractive growth markets where breakthrough technology solutions are in high demand. NetScientific’s investment model identifies late-stage translational research projects developing cutting-edge technologies in its disease focus areas. NetScientific then builds on accredited research, the previous stages of which have already been funded by academic institutions, governments and science foundations, to take the projects to the point of commercialisation. NetScientific is an active investor providing extensive management support. This can involve the senior management team initially taking leadership roles in companies and building dedicated management teams as the companies develop and grow.
London, GB
23 (est)

Key People at Netscientific

Farad Azima

Farad Azima

Michael Boyce-Jacino

Michael Boyce-Jacino


Netscientific Locations

London, GB

Netscientific Metrics

Netscientific Summary

Market capitalization

£32.4 M

Closing share price


Netscientific Financials

FY, 2013FY, 2015


£178 K£78.6 K

Gross profit

££72.1 K

Gross profit Margin, %


Operating expense total

££11.5 M

Netscientific Market Value History

Netscientific Company Life